(Q46720645)

24 December 2017

title

Efficacy of glutamine-supplemented parenteral nutrition on short-term survival following allo-SCT: a randomized study (English)

1 reference

24 December 2017

author name string

H O da Gama Torres

1

1 reference

24 December 2017

E G Vilela

2

1 reference

24 December 2017

A S da Cunha

3

1 reference

24 December 2017

E M A Goulart

4

1 reference

24 December 2017

M H C Souza

5

1 reference

24 December 2017

A C C Aguirre

6

1 reference

24 December 2017

W M Azevedo

7

1 reference

24 December 2017

F M Lodi

8

1 reference

24 December 2017

A A Silva

9

1 reference

24 December 2017

H N S Bittencourt

10

1 reference

24 December 2017

language of work or name

English

0 references

publication date

3 March 2008

1 reference

24 December 2017

Bone Marrow Transplantation

published in

1 reference

24 December 2017

volume

41

1 reference

24 December 2017

issue

12

1 reference

24 December 2017

page(s)

1021-1027

1 reference

24 December 2017

Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study

cites work

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.27

Glutamine delays spontaneous apoptosis in neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.27

Gastro-intestinal toxicity related to bone marrow transplantation: disruption of the intestinal barrier precedes clinical findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.27

7 January 2021

Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.27

7 January 2021

Body composition changes in marrow transplant recipients receiving total parenteral nutrition

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.27

7 January 2021

Energy requirements of parenterally fed bone marrow transplant recipients.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.27

7 January 2021

Plasma glutamine depletion and patient outcome in acute ICU admissions

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.27

7 January 2021

Parenteral L-alanyl-L-glutamine improves 6-month outcome in critically ill patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.27

7 January 2021

Glutamine alimentation in catabolic state

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.27

7 January 2021

Glutamine: essential for immune nutrition in the critically ill.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.27

7 January 2021

L-alanyl-L-glutamine dipeptide-supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: the French controlled, randomized, double-blind, multicenter study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.27

7 January 2021

https://api.crossref.org/works/10.1038%2FBMT.2008.27

1 reference

7 January 2021

Effect of route and type of nutrition on intestine-derived inflammatory responses

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.27

7 January 2021

Total parenteral nutrition with glutamine in bone marrow transplantation and other clinical applications (a randomized, double-blind study)

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.27

7 January 2021

Parenteral glutamine dipeptide supplementation does not ameliorate chemotherapy-induced toxicity

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.27

7 January 2021

Oral and parenteral glutamine in bone marrow transplantation: a randomized, double-blind study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.27

7 January 2021

Standardized parenteral alanyl-glutamine dipeptide supplementation is not beneficial in autologous transplant patients: a randomized, double-blind, placebo controlled study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.27

7 January 2021

A randomised, double-blinded, placebo-controlled, pilot study of parenteral glutamine for allogeneic stem cell transplant patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.27

7 January 2021

Nutritional and metabolic support in patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.27

7 January 2021

Intestinal permeability and antigliadin antibody test for monitoring adult patients with celiac disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.27

7 January 2021

Outcome of ethnic minorities with acute or chronic leukemia treated with hematopoietic stem-cell transplantation in the United States.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.27

7 January 2021

Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.27

7 January 2021

Parenteral glutamine protects hepatic function during bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.27

7 January 2021

Measuring mucosal damage induced by cytotoxic therapy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.27

7 January 2021

Prospective evaluation of gut mucosal barrier injury following various myeloablative regimens for haematopoietic stem cell transplant

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.27

7 January 2021

Glutamine: commercially essential or conditionally essential? A critical appraisal of the human data

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.27

7 January 2021

Glutamine: do the data support the cause for glutamine supplementation in humans?

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.27

7 January 2021

Intestinal permeability in patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.27

7 January 2021

Intestinal permeation and gastrointestinal disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.27

7 January 2021

Intestinal permeability and systemic infections in critically ill patients: effect of glutamine.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.27

7 January 2021

Test conditions greatly influence permeation of water soluble molecules through the intestinal mucosa: need for standardisation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.27

7 January 2021

Geography of intestinal permeability and absorption

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.27

7 January 2021

Role of glutamine in immunologic responses

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.27

7 January 2021

The essential role of L-glutamine in lymphocyte differentiation in vitro

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.27

7 January 2021

Glutamine requirements in the generation of lymphokine-activated killer cells.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.27

7 January 2021

Does glutamine contribute to immunosuppression after major burns?

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.27

7 January 2021

Glutamine and macrophage function

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.27

7 January 2021

Glutamine accelerates interleukin-6 production by rat peritoneal macrophages in culture

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.27

7 January 2021

Supplemental glutamine augments phagocytosis and reactive oxygen intermediate production by neutrophils and monocytes from postoperative patients in vitro

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.27

7 January 2021

Glutamine-supplemented total parenteral nutrition enhances T-lymphocyte response in surgical patients undergoing colorectal resection

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.27

7 January 2021

The effect of glutamine-supplemented total parenteral nutrition on nitrogen economy depends on severity of diseases in surgical patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.27

7 January 2021

Glutamine-enriched total parenteral nutrition maintains intestinal interleukin-4 and mucosal immunoglobulin A levels

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.27

7 January 2021

TPN decreases IL-4 and IL-10 mRNA expression in lipopolysaccharide stimulated intestinal lamina propria cells but glutamine supplementation preserves the expression

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.27

7 January 2021

Influence of glutamine on cytokine production by human gut in vitro

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.27

7 January 2021

Glutamine-supplemented total parenteral nutrition reduces blood mononuclear cell interleukin-8 release in severe acute pancreatitis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.27

7 January 2021

Effect of glutamine-enriched total parenteral nutrition in patients with acute pancreatitis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.27

7 January 2021

Adverse clinical consequences of hyperglycemia from total parenteral nutrition exposure during hematopoietic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.27

7 January 2021

Identifiers

DOI

10.1038/BMT.2008.27

1 reference

24 December 2017

1 reference

24 December 2017